Arix Bioscience PLC | WebDisclosure

PRESS RELEASE

published on 11/03/2023 at 17:30, 2 years 4 months ago

PDMR Notification & Director Shareholding
PRESS RELEASE

published on 11/02/2023 at 19:20, 2 years 4 months ago

PDMR Notification & Director Shareholding
PRESS RELEASE

published on 11/01/2023 at 17:30, 2 years 4 months ago

Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
PRESS RELEASE

published on 10/24/2023 at 08:00, 2 years 5 months ago

Portfolio company Harpoon Therapeutics announces up to $150 million private placement
PRESS RELEASE

published on 10/06/2023 at 08:00, 2 years 5 months ago

Unaudited NAV for September 2023
PRESS RELEASE

published on 09/27/2023 at 08:01, 2 years 5 months ago

Interim Results for the Six Months Ended 30 June 2023
PRESS RELEASE

published on 09/27/2023 at 08:00, 2 years 5 months ago

Board Change
PRESS RELEASE

published on 09/14/2023 at 08:01, 2 years 6 months ago

Notice of Results and Investor Presentation
PRESS RELEASE

published on 09/14/2023 at 08:00, 2 years 6 months ago

Unaudited NAV for August 2023
PRESS RELEASE

published on 08/07/2023 at 08:00, 2 years 7 months ago

Unaudited NAV for July 2023

Published on 03/26/2026 at 08:57, 8 hours 33 minutes ago

Communiqué Edenred
Published on 03/26/2026 at 08:57, 8 hours 33 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 10 hours 1 minute ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 10 hours 1 minute ago

BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 22 hours 37 minutes ago

CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026

News